Past Working Group awardees

Review all abstracts and presentations on ESC 365, the Cardiology Knowledge Hub.

Awardees 2020

Risa Ramadhiani: Endothelial cell premature senescence exacerbates pulmonary arterial hypertension through contact-mediated interaction with vascular smooth muscle cells

Chayakrit Krittanawong: A genome-wide association study identifies novel genetic loci associated with pulmonary embolism

Awardees 2019

• Mehreen Batool (Cologne, DE) for the abstract on Vascular Diseases ‒ Hypertension, Pulmonary Hypertension:
  The six-transmembrane protein Stamp2 protects from hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via actions in mononuclear cells and CXCL12
• Ryo Kurosawa (Sendai, JP) for the abstract on Vascular Diseases ‒ Hypertension, Pulmonary Hypertension:
  Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension
• Thomas Hofbauer (Vienna, AT) for the abstract on Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure – Pathophysiology and Mechanisms:
  Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution
• Gusti Rizky Teguh Ryanto (Kobe, JP) for the abstract on Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure – Pathophysiology and Mechanisms:
  Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells
• Pamela Alarcon (Buenos Aires, AR) for the abstract on Pulmonary Embolism:
  Usefulness of different electrocardiographic patterns as predictors of in-hospital mortality in acute pulmonary embolism
• Takahiro Hiraide (Tokyo, JP) for the abstract on Pulmonary Hypertension:
  Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases

Awardees 2018

• Karl-Patrik Kresoja (Germany) for the abstract on Pulmonary Embolism:
  Predicting in-hospital major bleeding in pulmonary embolism patients treated with systemic thrombolytic therapy
• Pedro Freitas (Portugal) for the abstract on Pulmonary Embolism:
  Derivation and external validation of a new score to predict pulmonary embolism related mortality and/or thrombolysis at 30-days
• Ines Garcia Lunar (Spain) for the abstract on Pulmonary Hypertension:
  Effect of pulmonary artery denervation in a translational model of chronic postcapillary pulmonary hypertension
• Pierre Guignant (France) for the abstract on Pulmonary Hypertension:
  Phenomapping for re-classification of patients with pulmonary hypertension at high risk

Awardees 2017

• Tatsuo Aoki (Sendai, JP), for his abstract on Chronic pulmonary hypertension:
  Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension - long-term effects and complications
• Stefano Barco (Mainz, GE), for his abstract on Acute pulmonary embolism:
  Determinants of the long-term haemodynamic course and late sequelae after acute intermediate-risk pulmonary embolism: results from a randomized thrombolysis trial

• Barbara Girerd (Le Kremlin Bicêtre, FR), for her abstract on Pulmonary circulation:
  Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease

• Aleksander Kempny (London, UK) for his abstract on Acute pulmonary embolism:
  Incidence of pulmonary embolism, associated mortality and bleeding risk in england between 1998-2015

• Karl-Patrik Kresoja (Berlin, GE) for his abstract on Acute pulmonary embolism:
  Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism

• Taijyu Satoh (Sendai, JP), for his abstract on Chronic pulmonary hypertension:
  Thrombin activatable fibrinolysis inhibitor promotes development of chronic thromboembolic pulmonary hypertension -A possible novel therapeutic target-

Awardees 2016

• Erik Klok (Vienna, AT), for its abstract on Acute Pulmonary Embolism:
  Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation
• Mona Sahlholdt Hansen (Aarhus N, DK), for its abstract on Right Ventricular Function:
  Levosimendan prevents and reverts pressure-overload induced right ventricular failure
• Max-Paul Winter (Vienna, AT), for its abstract on Chronic Pulmonary Hypertension:
  A new experimental model of pulmonary arterial hypertension- KDR knock out
• Kenzo Ichimura (Fukuoka, JP), for its abstract on Chronic Pulmonary Hypertension:
  Nanoparticle-mediated targeting of pitavastatin into small pulmonary arteries by intravenous administration attenuates the progression of monocrotaline-induced pulmonary arterial hypertension in rats
• Sabina Rosset (Lausanne,CH), for its abstract on Chronic Pulmonary Hypertension:
  Severe ventricular interdependence as a cause of misclassification of group 2 pulmonary hypertension

Awardees 2015

• Mario Gerges (Vienna,AT) for its abstract on Right ventricular function:
  Combined pre and post-capillary pulmonary hypertension in chronic heart failure: epidemiology, right ventricular function and survival
• Erik Klok (Leiden,NL) for its abstract on Acute pulmonary embolism:
  Withholding anticoagulation after negative CTPA is safe in patients with a likely clinical probability of PE
• Hideya Shigyo (Suita,JP) for its abstract on Pulmonary circulation:
  Efficacy and safety of first-line oral triple upfront combination therapy in severe pulmonary arterial hypertension patients
• Kasper Hasseriis Andersen (Copenhagen,DK) for its abstract on Chronic pulmonary hypertension:
  Venous remodelling in COPD pulmonary hypertension and idiopathic pulmonary arterial hypertension

Awardees 2014

4 Pulmonary Hypertension Awards (Unrestricted grant provided by Pfizer Limited):

• Yaguo Zheng: Oral targeted therapies in the treatment of pulmonary arterial hypertension: a meta-analysis of clinical trials
• Christian Gerges: Pulmonary artery occlusion waveform analysis for the assessment of pulmonary vascular disease in pulmonary hypertension due to left heart disease
• Guido Claessen: Sildenafil increases stroke volume during exercise in patients with chronic thromboembolic pulmonary hypertension
• Ana Garcia-Alvarez: Long-term oral B3-agonist treatment reduces pulmonary vascular resistance and improves right ventricular function in a swine model of chronic postcapillary pulmonary hypertension

2 Venous Thromboembolism Awards:

• Erik Klok: Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism
• Anja Kaeberich: Optimized high sensitive troponin T cut-off values for risk stratification of normotensive patients with pulmonary embolism

Awardees 2013

2 Venous Thromboembolism Awards:

Delphine Baudouy: B blood type is a strong risk factor for venous thromboembolism recurrence
Mareike Lankeit: Angiopoietin-2 - a novel biomarker for risk stratification of acute pulmonary embolism

2 Pulmonary Hypertension Awards:

Max-Paul Winter: Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Jose Manuel Montero Cabezas: Demythologizing pulmonary artery aneurysm: prevalence and associated complications in a large pulmonary arterial hypertension population

Awardees 2012

Abstract: Plasma MR-proADM is superior to NT-proBNP for all-cause short term mortality prediction in acute pulmonary embolismby Justyna Pedowska-Wloszek
Abstract: Pulmonary embolism in Sweden, a national cohort and survival analysis, by Therese Anderson
Abstract: Right ventricular hypertrophy and failure abolish cardioprotection by ischemic preconditioning, by Asger Andersen
Abstract: Survival in pre-capillary pulmonary hypertension: does echocardiography make the difference?, by Julia Grapsa
Abstract: Egr-1 expression is specific for neointimal development in both human and experimental PAH, by Michael Dickinson
Abstract: Treatment of decompensated left-sided heart failure lowers right ventricular pulsatile load and increases the pulmonary arterial time constant, by Matthias Dupont

Awardees 2011

Abstract: Pulmonary arterial stroke volume: a new and strong prognostic factor in pediatric pulmonary arterial hypertension
by Johannes Menno Douwes (NL)
Abstract: Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
by Barbara Girerd (FR)
Abstract: ESC-ERS 2009 pulmonary hypertension guidelines: an evaluation study in 9 European countries (the guide to PH study)
by Enri Leci (IT)
Abstract: Survival in patients with pulmonary arterial hypertension associated with connective tissue disease over the past decade
by Christopher Valerio (UK)
Abstract: Predictive value of the new highly sensitive troponin T assay compared to a clinical score in normotensive patients with acute pulmonary embolism: a prospective external validation study by Mareike Lankeit (DE)
Abstract: In-hospital major bleeding predicts mortality in patients with objectively confirmed pulmonary embolism
by Anna Budaj-Fidecka (PL)

Awardees 2010

Abstract: Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies, by Elena Beciani
Abstract: Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study, by Zhi-Cheng Jing